Digestive diseases
Conditions
Interventions
group A:Nabuphine 0.05mg/kg slow intravenous bolus for more than 30s
group B:Nabuphine 0.1mg/kg slow intravenous bolus for more than 30s
group C:Nabuphine 0.15mg/kg slow intravenous bolus for more than 30s
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients planning to undergo painless gastroscopy or enteroscopy; 18-65 years old, no gender restriction; Body Mass Index (BMI) 18.5 ~ 30 kg / m2; American Society of Anesthesiologists (ASA) grade I ~ III.
Exclusion criteria
Exclusion criteria: Patients with severe liver and kidney dysfunction; those who are allergic to emulsions and opioids; those who cannot cooperate without communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vomiting response during gastroscope insertion;Body movement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Induction time;Eyes open time;Total propofol dosage;Satisfaction score; | — |
Countries
China
Contacts
Public ContactXiao Weimin
Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed